Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

CHOP chemotherapy causes many side effects but is generally well tolerated.

The supplement did not work better than a placebo for hair loss in women over 60.

MCHR2 gene duplications may be linked to alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

AC5 improves hair loss and hair quality with high satisfaction rates.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

PRP may help treat female hair loss, but more research needed.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

PRP injections did not significantly improve hair growth.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

LLLT promotes hair growth and improves hair density safely in men and women.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A structured exercise program significantly improved the physical and mental well-being of young women with PCOS.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.